🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a study to evaluate safety and effectiveness of Ilaris in adult and...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2025-03-29
Trial ID
NCT06838143
Treatments Being Tested
The purpose of this study is to determine if once-daily treatment with colc...
Status
Completed
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01451645
Treatments Being Tested
The purpose of this study is to assess the potential for pegloticase with m...
Status
Completed
Location
University of Alabama
Start Date
2019-06-13
Trial ID
NCT03994731
The overall objective of the study is to assess the efficacy, safety, toler...
Status
Completed
Location
Orthopedic Physicians Alaska
Start Date
2018-09-26
Trial ID
NCT03635957
The purpose of this study is to evaluate and compare the relative bioavaila...
Status
Completed
Location
Novum Pharmaceutical Research Services
Start Date
2010-05
Trial ID
NCT01130051
Treatments Being Tested
This study wants to see if the medicine colchicine can help lower inflammat...
Status
Recruiting
Location
University of Kentucy
Start Date
2026-01-16
Trial ID
NCT07287345
Treatments Being Tested
Colchicine is a supressor of hepatic CYP1A2 and theophylline is a sensitive...
Status
Completed
Location
PRACS Institute, Ltd. - Cetero Research
Start Date
2008-08
Trial ID
NCT00983905
Treatments Being Tested
Ritonavir is a potent inhibitor of CYP3A4, one of the enzymes responsible f...
Status
Completed
Location
PRACS Institute, Ltd. - Cetero Research
Start Date
2008-07
Trial ID
NCT00983515
Treatments Being Tested
Colchicine is a substrate for both cytochrome P450 3A4 (CYP3A4) and P-glyco...
Status
Completed
Location
PRACS Institute, Ltd. - Cetero Research
Start Date
2008-08
Trial ID
NCT00983931
Treatments Being Tested
Azithromycin is a possible weak to moderate inhibitor of CYP3A4, one of the...
Status
Completed
Location
Multiple Locations
Start Date
2008-07
Trial ID
NCT00983294
Treatments Being Tested